Monika Lessl is Head of Corporate Innovation and R&D at Bayer AG promoting Innovation throughout the organization. She is leading strategic approaches to promote Bayer’s Innovation capabilities, foster Open Innovation, strengthen cross-functional R&D capabilities with a focus on Data Science and drives Social Innovation. Prior to this role she was head of Innovation Strategy at Bayer AG where she developed Bayer’s Innovation Agenda. Until 2013 she led the External Innovation Therapeutics function at Bayer HealthCare in Berlin, Germany, where she designed the therapeutic partnering strategies and established a number of novel and innovative partnership models with academia, biotech and Venture Capital as well as open innovation initiatives. Prior to this she was CEO of the Ernst Schering Foundation, where she promoted innovative programs to foster emerging research areas and excellent young scientists. She spent 8 years as a scientist and lab head in the research laboratories of Schering AG performing drug development in the area of Women’s Health Care.
November 13, 2019
- 9:25 amKeynote Panel: The changing R&D landscape: How should the Lab of the Future respond?